Winning the Digital Disruption Game: Answering the ‘CAST’ing Call

Safeguard Insights

April 6, 2012

Week in Review: Strong First Quarter for IPOs, JOBS Act Becomes Law

The first quarter of 2012 has come and gone, leaving positive signs for venture capitalists. Twenty venture-backed start-ups made their IPO in the past three…

Posted by John E. Shave III

March 23, 2012

Week in Review: Technology and Healthcare Convergence Seeds New Partnerships

The same technologies driving Enterprise 3.0 have also been revolutionizing health management. This convergence of technology and healthcare has built up momentum recently through new…

Posted by John E. Shave III

March 9, 2012

Week in Review: The Role of CIO in Enterprise 3.0, Medivo Goes Mobile, and Alverix Adds Key Patents

Readers of this blog are well aware that entrepreneurship is one of our key themes—from our partner company CEO Q&A Series to our book recommendations…

Posted by John E. Shave III

February 10, 2012

Week in Review: IPO Madness and New Partner Company Spongecell

The past two weeks were brought to you by the letters IPO. From Facebook’s well-documented filing to this week’s IPO price cuts, a flurry of…

Posted by John E. Shave III

January 27, 2012

Week in Review: Venture Investment Grew 22% YoY; Alverix and The Doctors; Beyond.com Among Future 50; MediaMath on FoxBusiness

Last year was a strong year for venture capital, according to the MoneyTree report issued by the National Venture Capital Association. Investments grew 22 percent…

Posted by John E. Shave III

November 18, 2011

Week in Review: Convergence between Life Sciences and Technology and A Look at New Partner Company Medivo

The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…

Posted by John E. Shave III

November 15, 2011

Opportunity in the Migraine Market for NuPathe

Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…

Posted by James A. Datin

November 4, 2011

Week in Review: Venture Capital Growth and MediaMath on the Talent Gap

According to a report published by Cambridge Associates LLC, private equity and venture capital funds in the U.S. continued to generate positive returns for their…

Posted by John E. Shave III

October 7, 2011

Recap: Safeguard Scientifics Investor Day 2011

Earlier this week we held our Fifth Annual Investor Day 2011 where investors and analysts heard presentations from Safeguard executives and  highlighted partner companies on…

Posted by John E. Shave III

Content